{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:33:44Z","timestamp":1778679224187,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["19\\u201333-90017"],"award-info":[{"award-number":["19\\u201333-90017"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["33-90017"],"award-info":[{"award-number":["33-90017"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejmech.2021.113352","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T04:24:26Z","timestamp":1616041466000},"page":"113352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Insertion of metal carbenes into the anilinic N\u2013H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms"],"prefix":"10.1016","volume":"218","author":[{"given":"Tatiana","family":"Sharonova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-2599","authenticated-orcid":false,"given":"Polina","family":"Paramonova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav","family":"Kalinin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6408-8329","authenticated-orcid":false,"given":"Alexander","family":"Bunev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rovshan \u0415.","family":"Gasanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Sharoyko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana B.","family":"Tennikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0413-7413","authenticated-orcid":false,"given":"Dmitry","family":"Dar\u2019in","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Krasavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113352_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113352_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-94-007-7359-2_3","article-title":"Catalytic mechanism of \u03b1-class carbonic anhydrases: CO2 hydration and proton transfer","volume":"75","author":"Boone","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113352_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/metabo7040056","article-title":"An overview of the bacterial carbonic anhydrases","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2021.113352_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/14756366.2019.1571273","article-title":"Inhibition of \u03b1-, \u03b2-, \u03b3-, \u03b4-, \u03b6- and \u03b7-class carbonic anhydrases from bacteria, fungi, algae, diatoms and protozoans with famotidine","volume":"34","author":"Angeli","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1080\/14756366.2018.1490733","article-title":"Inhibition of \u03b1-, \u03b2-, \u03b3-, and \u03b4-carbonic anhydrases from bacteria and diatoms with N\u2032 -aryl- N -hydroxy-ureas","volume":"33","author":"Berrino","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22020571","article-title":"Effect of sulfonamides and their structurally related derivatives on the activity of \u03b9-carbonic anhydrase from burkholderia territorii","volume":"22","author":"De Luca","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113352_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/14756366.2016.1217856","article-title":"Cloning, expression and purification of the complete domain of the \u03b7-carbonic anhydrase from Plasmodium falciparum","volume":"31","author":"Del Prete","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-94-007-7359-2_15","article-title":"Carbonic anhydrase inhibitors drug design","volume":"75","author":"McKenna","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113352_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cbpa.2010.06.161","article-title":"Perspectives on carbonic anhydrase","volume":"157","author":"Gilmour","year":"2010","journal-title":"Comp. Biochem. Physiol. - A Mol. Integr. Physiol."},{"key":"10.1016\/j.ejmech.2021.113352_bib11","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.bbapap.2011.07.007","article-title":"Molecular evolution and selection pressure in alpha-class carbonic anhydrase family members","volume":"1814","author":"McDevitt","year":"2011","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2021.113352_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-94-007-7359-2_2","article-title":"Physiological functions of the alpha class of carbonic anhydrases","volume":"75","author":"Frost","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113352_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-94-007-7359-2_1","article-title":"Overview of the carbonic anhydrase family","volume":"75","author":"McKenna","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113352_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13543776.2019.1629419","article-title":"Carbonic anhydrases as disease markers","volume":"29","author":"Zamanova","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.113352_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/156802607780636690","article-title":"Carbonic anhydrases as drug targets - an overview","volume":"7","author":"Supuran","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115086","article-title":"Highly hydrophilic 1,3-oxazol-5-yl benzenesulfonamide inhibitors of carbonic anhydrase II for reduction of glaucoma-related intraocular pressure","volume":"27","author":"Kalinin","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib17","series-title":"Carbon. Anhydrases Biochem. Pharmacol. An Evergr. Pharm. Target","first-page":"367","article-title":"Carbonic anhydrase inhibitors for the treatment of neuropathic pain and arthritis","author":"Nocentini","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113352_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728214.2012.664132","article-title":"Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity","volume":"17","author":"Supuran","year":"2012","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2021.113352_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-94-007-7359-2_17","article-title":"Glaucoma and the applications of carbonic anhydrase inhibitors","volume":"75","author":"Scozzafava","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113352_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113352_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors","volume":"12","author":"Supuran","year":"2020","journal-title":"J.\u00a0Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113352_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1573399812666161214122351","article-title":"The role of carbonic anhydrase in hepatic glucose production","volume":"14","author":"Ismail","year":"2018","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.ejmech.2021.113352_bib23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/14756366.2020.1766455","article-title":"Carbonic anhydrase modulation of emotional memory. Implications for the treatment of cognitive disorders","volume":"35","author":"Blandina","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib25","series-title":"Drug Des. Zinc-Enzyme Inhib.","first-page":"39","article-title":"Zinc binding functions in the design of carbonic anhydrase inhibitors","author":"Winum","year":"2009"},{"key":"10.1016\/j.ejmech.2021.113352_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ica.2017.03.038","article-title":"Sulfonamide carbonic anhydrase inhibitors: zinc coordination and tail effects influence inhibitory efficacy and selectivity for different isoforms","volume":"470","author":"Ferraroni","year":"2018","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.ejmech.2021.113352_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.03.023","article-title":"Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site","volume":"132","author":"Hou","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib28","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/453543","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","volume":"2015","author":"Pinard","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejmech.2021.113352_bib31","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113352_bib32","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.bmc.2017.02.018","article-title":"Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds","volume":"25","author":"Krasavin","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib33","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.7b00300","article-title":"Lucky Switcheroo: dramatic potency and selectivity improvement of imidazoline inhibitors of human carbonic anhydrase VII","author":"Kalinin","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113352_bib34","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/acs.jmedchem.5b01144","article-title":"Discovery of 1,1\u2032-biphenyl-4-sulfonamides as a new class of potent and selective carbonic anhydrase XIV inhibitors","volume":"58","author":"La Regina","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib35","unstructured":"A study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal cancer in Subjects positive for CAIX - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03450018?term=SLC-0111 (accessed 10.02.21)."},{"key":"10.1016\/j.ejmech.2021.113352_bib36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.bmc.2011.01.016","article-title":"Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site","volume":"19","author":"Durdagi","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib37","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.bmcl.2004.09.061","article-title":"Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties","volume":"14","author":"Chazalette","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113352_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111642","article-title":"From random to rational: a discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction","volume":"182","author":"Kalinin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/14756366.2019.1705291","article-title":"Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors","volume":"35","author":"Poli","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib40","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.0c06153","article-title":"Predicting isoform-selective carbonic anhydrase inhibitors via machine learning and rationalizing structural features important for selectivity","author":"Galati","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2021.113352_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.113352_bib42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/14756366.2020.1801674","article-title":"Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents","volume":"35","author":"Krasavin","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nchem.2034","article-title":"Efficient discovery of bioactive scaffolds by activity-directed synthesis","volume":"6","author":"Karageorgis","year":"2014","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-1996-5440","article-title":"Diazotransfer reagents 1","volume":"1996","author":"Bollinger","year":"1996","journal-title":"Synlett."},{"key":"10.1016\/j.ejmech.2021.113352_bib45","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1039\/C9CC02042J","article-title":"A\u00a0\u201csulfonyl-azide-free\u201d (SAFE) aqueous-phase diazo transfer reaction for parallel and diversity-oriented synthesis","volume":"55","author":"Dar\u2019in","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113352_bib46","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.tetlet.2019.06.008","article-title":"The use of \u221d-diazo-\u03b3-butyrolactone in the B\u00fcchner-Curtius-Schlotterbeck reaction of cyclic ketones: a facile entry into spirocyclic scaffolds","volume":"60","author":"Shershnev","year":"2019","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113352_bib47","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1021\/acs.joc.9b02030","article-title":"\u03b1-Acyl-\u03b1-diazoacetates in transition-metal-free \u03b2-lactam synthesis","volume":"84","author":"Synofzik","year":"2019","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib48","doi-asserted-by":"crossref","first-page":"151120","DOI":"10.1016\/j.tetlet.2019.151120","article-title":"A\u00a0novel approach to biologically relevant oxazolo[5,4-d]pyrimidine-5,7-diones via readily available diazobarbituric acid derivatives","volume":"60","author":"Gecht","year":"2019","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113352_bib49","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1055\/s-0040-1707525","article-title":"Facile one-pot access to \u03b1-Diazo-\u03b2-ketosulfones from sulfonyl chlorides and \u03b1-haloketones","volume":"52","author":"Dar\u2019in","year":"2020","journal-title":"Synth. Met."},{"key":"10.1016\/j.ejmech.2021.113352_bib50","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1002\/ejoc.202000446","article-title":"Synthetic studies towards CH-diazomethane sulfonamides: a novel type of diazo reagents","volume":"2020","author":"Bubyrev","year":"2020","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib51","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1002\/ejoc.201900565","article-title":"Rh2(esp)2-Catalyzed coupling of \u03b1-Diazo-\u03b3-butyrolactams with aromatic amines","volume":"2019","author":"Zhukovsky","year":"2019","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib52","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib53","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib54","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/metabo10100412","article-title":"Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2021.113352_bib55","article-title":"Radiotracers for positron emission tomography (PET) targeting tumour-associated carbonic anhydrase isoforms","author":"Burianova","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib56","first-page":"773","article-title":"Differential regulation and prognostic significance of endogenous hypoxic markers in endometrial carcinomas","volume":"39","author":"Dong Soo","year":"2018","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ejmech.2021.113352_bib57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2217\/14750708.4.3.355","article-title":"Therapeutic applications of the carbonic anhydrase inhibitors","volume":"4","author":"Supuran","year":"2007","journal-title":"Therapy"},{"key":"10.1016\/j.ejmech.2021.113352_bib58","article-title":"Current medical therapy and future trends in the management of glaucoma treatment","volume":"2020","author":"Cvenkel","year":"2020","journal-title":"J.\u00a0Ophthalmol."},{"key":"10.1016\/j.ejmech.2021.113352_bib59","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113352_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756360902784425","article-title":"Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies","volume":"24","author":"Ebbesen","year":"2009","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.ejmech.2021.113352_bib62","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2021.113352_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2021.113352_bib64","first-page":"1","article-title":"How and why are cancers acidic? Carbonic anhydrase ix and the homeostatic control of tumour extracellular ph","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2021.113352_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113352_bib66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41416-018-0216-5","article-title":"Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in\u00a0vivo","volume":"119","author":"Lee","year":"2018","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113352_bib67","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2174\/09298673113209990227","article-title":"Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers","volume":"21","author":"Ilardi","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib68","unstructured":"Inhibition of carbonic anhydrase in combination with Platinum and Etoposide-based Radiochemotherapy in patients with localized small cell lung cancer - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03467360 (accessed February 10.02.21.)."},{"key":"10.1016\/j.ejmech.2021.113352_bib69","unstructured":"Trial to determine Optimal phase II dose of the oral dual CAIX inhibitor\/radiosensitizer - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02216669?term=carbonic+anhydrase&draw=4 (accessed 10.02.21.)."},{"key":"10.1016\/j.ejmech.2021.113352_bib70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijo.2015.3253","article-title":"CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer","volume":"48","author":"Chu","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2021.113352_bib71","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bioorg.2018.09.007","article-title":"Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in\u00a0vitro antitumor activity towards colon cancer","volume":"81","author":"Eldehna","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib73","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/14756366.2020.1712596","article-title":"Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX\/XII and of human thioredoxin reductase","volume":"35","author":"Krasavin","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102484","article-title":"Novel diamide-based benzenesulfonamides as selective carbonic anhydrase ix inhibitors endowed with antitumor activity: synthesis, biological evaluation and in silico insights","volume":"20","author":"Abdelrahman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113352_bib75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.7b00903","article-title":"Seven year itch: pan-assay interference compounds (PAINS) in 2017 - utility and limitations","volume":"13","author":"Baell","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113352_bib76","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/ejoc.201900133","article-title":"Synthetic exploration of \u03b1-diazo \u03b3-butyrolactams","volume":"2019","author":"Zhukovsky","year":"2019","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib77","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1055\/s-0039-1690613","article-title":"Practical application of the aqueous \u201csulfonyl-azide-free\u201d (SAFE) diazo transfer protocol to less \u03b1-C-H acidic ketones and esters","volume":"51","author":"Dar\u2019in","year":"2019","journal-title":"Synth. Met."},{"key":"10.1016\/j.ejmech.2021.113352_bib78","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1021\/jm060967z","article-title":"A\u00a0novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by \u201cclick-tailing\u201d","volume":"49","author":"Wilkinson","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib79","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.2174\/138161210793429869","article-title":"Carbonic anhydrase inhibitors developed through \u2018click tailing\u2019","volume":"16","author":"Lopez","year":"2010","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.113352_bib80","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/jm061320h","article-title":"Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides","volume":"50","author":"Wilkinson","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113352_bib81","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/ml500196t","article-title":"Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry","volume":"5","author":"Pala","year":"2014","journal-title":"ACS Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:52:06Z","timestamp":1778676726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":81,"alternative-id":["S0223523421002014"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113352","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insertion of metal carbenes into the anilinic N\u2013H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113352"}}